LONDON, June 20, 2016 /PRNewswire/ --
Building on the trusted reputation of MOVICOL(R) over the last 20 years.
Demonstrating Norgine's expertise in gastroenterology with the development and
commercialisation of innovative products.
Norgine B.V. today announced the launch of MOVICOL(R) Ready to Take in Germany. In Germany it is called MOVICOL(R) trinkfertig. MOVICOL(R) Ready to Take is used for the treatment of acute and chronic constipation in adults, adolescents and the elderly.
(Logo: http://photos.prnewswire.com/prnh/20130829/633895-a )
MOVICOL(R) Ready to Take is a ready mixed, pocket size dose that can be taken anywhere, at any time. It is an extension to the product line of the well-established MOVICOL(R) brand which has been available for over 20 years in Europe and Australia/New Zealand via Norgine's infrastructure and in the rest of world through a network of partners.
Peter Martin, COO at Norgine said: "The launch of MOVICOL(R) Ready to Take in Germany reinforces Norgine's ability to develop and commercialise products that offer value to healthcare professionals, health systems and more importantly that meet patients' needs."
He added: "The first launch of the new MOVICOL(R) Ready to Take is significant for Norgine, as it builds on MOVICOL(R)'s leading position, but it also continues to demonstrate Norgine's gastroenterology expertise and capabilities as a European specialist pharma company."
Norgine anticipates launching MOVICOL(R) Ready to Take through its European infrastructure later on this year.
To view full release go to http://www.norgine.com
1. MOVICOL Ready To Take. Instructions For Use. September 2015.
Isabelle Jouin, T: +44 (0)1895 453643
Charlotte Andrews, T: +44 (0)1895 453607
Follow us @norgine